 |
|
| Blog results | Results 1 - 10 of about 380 for neuroendocrine tumor experience. (0.36 seconds) |
| Sorted by relevance Sort by date |
| 13 Nov 2009 by "Renal Carincoid Guy" Good uptake, Boom your are dead NET tumors! SUMMARY SO FAR FROM MY PRRT EXPERIENCE. I was near death in Febr 2009, nowhere to go or treatment and denied . PRRT, if done correctly and in an experienced center, can extend your life. ... My journey thru Neuroendocrine Carcinoma... - http://www.renalcarcinoid.com/ [ More results from My journey thru Neuroendocrine Carcinoma... ] |
| 10 Nov 2009 by Berlin Flores I learned through a link to a blog site that Anna, a fellow employee from the Data and Catalog department, was diagnosed with Neuroendocrine Tumor Stage 3, a rare type of cancer. According to Kai Teves' researched article: ... Random Thoughts - http://blazingpenpusher.blogspot.com/ |
| 23 Nov 2009 by laughingwolf The prognosis for pancreatic cancer is usually very grim; Jobs said he had a rare, far less aggressive type, known as islet cell neuroendocrine tumor. After initially resisting the idea of conventional medical intervention and embarking ... paws and reflect... - http://laughing1wolf.blogspot.com/ |
| 19 Nov 2009 Qualifications: • 10+ years proven experience in identifying, cultivating, soliciting and stewarding major gifts from donors yielding at least 3 million dollars cumulatively, in a non-profit setting. ... The mission of the Caring for Carcinoid Foundation is to discover a cure for carcinoid and related neuroendocrine tumors (NETS). CFCF also works to eliminate the suffering of patients, families, and caregivers affected by carcinoid and related NETs. ... Bridgestar Active Job Postings - http://www.bridgestar.org/MyCareerCenter/SearchJobs.aspx |
| 17 Jun 2009 by "Renal Carcinoid Guy" it notes the national comprehensive cancer network (which i am not sure what that organization does or the power it has to be honest), have added octreotide therapy to neuroendocrine tumors guidelines. this is will be huge for patients ... My journey thru Neuroendocrine Carcinoma... - http://renalcarcinoid.blogspot.com/ |
| 12 Nov 2009 by Amit Deshwal The prognosis for pancreatic cancer is usually very grim; Jobs, however, stated that he had a rare, far less aggressive type known as islet cell neuroendocrine tumor. Remembering that I'll be dead soon is the most important tool I've ... Amit Deshwal's Weblog - http://earthisnotround.wordpress.com/ |
| 25 Aug 2009 Eason said he performed some transplants on patients with neuroendocrine tumor during his time at the Ochsner Clinic in New Orleans. While it's hard to specialize in such a rare cancer, since cases are so few, the experience he gained ... BusinessMirror - A broader look at today's... - http://businessmirror.com.ph/index.php?option=com... |
| 4 Nov 2009 by Toshihito Hanaoka This case reminds us that neuroendocrine tumor should be included in the differential diagnosis of a retroperitoneal mass although composite paraganglioma-ganglioneuroma in the retroperitoneum is very rare. .... Patel SR, Winchester DJ, Benjamin RS: A 15-year experience with chemotherapy of patients with paraganglioma. Cancer 1995, 76:1476-1480. PubMed Abstract | Publisher Full Text OpenURL. Tanaka T, Yoshimi N, Iwata H, Sugie S, Kato K, Sakamoto H, Mori H: Fine needle ... World Journal of Surgical Oncology - Latest... - http://www.wjso.com/ [ More results from World Journal of Surgical Oncology - Latest... ] |
| 3 Oct 2009 Study published in Journal of Clinical Oncology demonstrate antitumor benefit of Sandostatin LAR in advanced midgut neuroendocrine tumor (NET) patients - Data. ... "PROMID is a placebo-controlled, randomized trial that showed octreotide LAR can control tumor growth in all patients with NET of the midgut whether or not they experience symptoms," said PROMID lead investigator Professor Rudolf Arnold, Philipps-University, Marburg, Germany. "These are promising data for ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 16 Nov 2008 ORLANDO (EGMN) - Endoscopic mucosal resection of Barrett's esophagus can be a safe and effective alternative to esophagectomy, according to a retrospective study of long-term clinical experience at the University of Chicago Medical Center. The endoscopic technique also allows clinicians to downstage or upstage patients with ... Editors' Choice. Can octreotide delay neuroendocrine tumor progression? Phase III trial convincingly answers this long-standing question. ... OncologySTAT News - http://www.oncologystat.com/ [ More results from OncologySTAT News ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
